Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.29 USD | +0.06% | +2.07% | +21.27% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.40% | 14.32B | |
+11.45% | 306B | |
+11.98% | 153B | |
+52.00% | 124B | |
+22.70% | 83.43B | |
+12.21% | 78.06B | |
+21.06% | 62.81B | |
+14.05% | 60.08B | |
+13.10% | 49.91B | |
+32.75% | 37.05B |
- Stock Market
- Equities
- OVV Stock
- News Ovintiv Inc.
- RBC Raises Price Target on Ovintiv to $61 From $49, Keeps Sector Perform Rating